Muelheim, Germany

Heinrich Kladders

This inventor holds 27 USPTO granted patents and 1 published patent application, plus 3 CIPO patents and 12 EPO patents, primarily in Inhalation Devices. Top assignees: Boehringer Ingelheim International Gmbh, Boehringer Ingelheim Kg, Boehringer Ingelheim Gmbh. Active years: 1982-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Heinrich Kladders. Retrieved from https://idiyas.com/inventor/heinrich-kladders

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 27 

% Patents Active = 92.6

 

 

Average Co-Inventor Count = 2.9

ph-index = 11

Forward Citations = 578(Granted Patents)


Location History:

  • Ingelheim am Rhein, DE (1982 - 1989)
  • Ingelheim, DE (1996 - 1997)
  • Mulheim, DE (1998 - 1999)
  • Muelheim, DE (2001 - 2011)
  • Muelheim/Ruhr, DE (2012 - 2013)
  • Mulheim-Ruhr, DE (2013)
  • Muelheim-Ruhr, DE (2013 - 2021)

Company Filing History:


Years Active: 1982-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Nebulizer
Inhaler
Dosing Pump
Powder Inhaler
Cartridge System
Container
Atomizer
Pressure Compensation
Nozzle-System
Medicinal Liquid
Active Substance
Separator
27 patents (USPTO):Explore Patents

Title: Innovations by Heinrich Kladders: Pioneering Developments in Nebulizing and Inhalation Technology

Introduction

Heinrich Kladders, an esteemed inventor based in Muelheim, Germany, has made significant contributions to medical technology, particularly in nebulization and inhalation systems. With an impressive portfolio of 25 patents, Kladders has been at the forefront of innovations aimed at enhancing the delivery of pharmaceutical treatments.

Latest Patents

Among Kladders' latest innovations, two notable patents stand out. The first is a nebulizer designed for effectively nebulizing a liquid from a container. This device incorporates a liquid pump that withdraws the liquid in doses and pressurizes each dose for optimal nebulization. Additionally, an air pump is integrated to temporarily pressurize the liquid in the container, facilitating the withdrawal of liquid from a collapsible bag.

The second patent involves an inhalator and corresponding capsule designed for receiving a powdered pharmaceutical preparation. This invention details a capsule that allows the preparation to be expelled through at least one hole for inhalation. It features a mechanism in which the capsule is sealed during transport and opened upon use through a simple actuation of a pushing or pulling mechanism. This innovation not only enhances the user experience but also ensures the integrity of the pharmaceutical preparation until it is ready for use.

Career Highlights

Heinrich Kladders has been associated with notable companies in the pharmaceutical sector, including Boehringer Ingelheim International GmbH and Boehringer Ingelheim KG. His work in these organizations has allowed him to contribute to groundbreaking technological advancements, particularly in the realm of inhalation devices, significantly impacting patient care and treatment methods.

Collaborations

Throughout his career, Kladders has collaborated with esteemed colleagues such as Dieter Hochrainer and Matthias Hausmann. These partnerships have greatly influenced the development of his patented technologies, reflecting a strong collaboration within the field of medical innovation.

Conclusion

Heinrich Kladders exemplifies the spirit of innovation, combining technical expertise with a commitment to improving healthcare outcomes. His patents not only showcase his inventive prowess but also serve as vital contributions to the medical community, particularly in the effective delivery of inhaled therapeutics. As he continues his journey of innovation, Kladders remains a significant figure in the landscape of medical technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…